Recruitment has begun at three leading Cambridgeshire NHS Trusts for volunteers to take part in the nationwide COVID-19 vaccine trial.
Tags: spotlight-on-future-therapeutics future-therapeutics infectious-diseases covid-19 coronavirus
Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology.
Tags: spotlight-on-future-therapeutics medicine future-therapeutics covid-19 coronavirus
The world’s first licensed, downloadable artificial pancreas app for people with type 1 diabetes launches today, based on over a decade of research by Professor Roman Hovorka at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust.
Tags: spotlight-on-future-therapeutics future-therapeutics type-1-diabetes diabetes app
The race is on to find a vaccine against the new COVID-19 coronavirus. Professor Jonathan Heeney explains why a cautious approach is needed and how his team is using new technology developed for influenza and Ebola viruses to target the new infection.
Tags: spotlight-on-future-therapeutics future-therapeutics infectious-diseases
Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of diseases, according to research published today in Nature Medicine.
Tags: spotlight-on-future-therapeutics future-therapeutics diagnostic protein proteomics
Cambridge scientists are set to benefit from a major cash injection from Cancer Research UK and partners to develop radical new strategies and technologies to detect cancer at its earliest stage.
Tags: physics future-therapeutics cancer
Cambridge is to establish a University Enterprise Zone as part of a new government initiative announced today by Universities Minister Chris Skidmore.
Tags: innovation future-therapeutics
Chris Skidmore, Minister for Universities, Science, Research and Innovation, today announced a £30 million award to the University of Cambridge to support the new Cambridge Heart and Lung Research Institute (HLRI).
Tags: heart-disease spotlight-on-public-health future-therapeutics cardiovascular-disease-cvd cardiorespiratory cystic-fibrosis
Page 1 of 1